Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF711 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | LRP3 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | GOLGA8T | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | CEBPA | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | CD53 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-06 |
mRNA | ACAP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | DDX21 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | JADE3 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | PKIB | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |